← 產業報告目錄

Healthcare BPO Market by Size, Share, Trends by Outsourcing Models, Life Science (R&D, Manufacturing, Supply Chain, Sales & Marketing (Analytics)), Provider (Patient Care, RCM), Payer (Claims Management, Billing & Accounts), Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-07-10頁數 342報告編號 HIT2168

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The healthcare BPO market is projected to reach USD 694.3 billion by 2030, up from USD 417.7 billion in 2025, at a CAGR of 10.7% from 2025 to 2030. The growth of the healthcare BPO market is driven by increasing pressure to control rising healthcare costs and the growing reliance on outsourcing in the pharmaceutical and biopharmaceutical sectors. The integration of advanced data analytics and the rising adoption of AI-driven tools, particularly in drug discovery, are creating significant opportunities for market expansion during the forecast period. However, challenges persist, especially regarding limitations in data capture and management processes within Medicaid services, which may impede the full potential of outsourcing in certain segments of the market. “The claims management services segment accounted for the largest share in Healthcare BPO market.’’ Based on payer services, the healthcare BPO market is segmented into claims management services, integrated front-end services, back-office operations, member management services, product development and business acquisition services (PDBA), provider management services, care management services, billing and accounts management services, and HR services. In 2024, the claims management services segment accounted for the largest share of the healthcare BPO market, driven by the growing tendency of healthcare payers to outsource these critical functions. By outsourcing claims management, payer organizations can mitigate the risks of processing delays, financial penalties, and stakeholder dissatisfaction resulting from backlogs. As effective claims handling is vital for maintaining operational continuity and ensuring timely reimbursements, leveraging specialized BPO providers enables payers to enhance operational efficiency, reduce administrative costs, and improve accuracy and compliance in claims processing. “The sales and marketing service segment accounts for the largest share of the healthcare BPO market in the non-clinical category services.” Based on the life sciences services segment, the healthcare BPO market is divided into manufacturing, research & development, and non-clinical services. The non-clinical services segment is further categorized into sales and marketing services, supply chain management and logistics services, and other non-clinical services. In 2024, the sales and marketing services segment represents the largest share in the healthcare BPO market. The dominance of sales and marketing services within the non-clinical services segment of the healthcare BPO market is primarily due to the intricate regulatory landscape of the pharmaceutical industry. As regulations constantly evolve, pharmaceutical companies are compelled to focus their resources on core activities such as research and development and production. Consequently, this has increased the demand for specialized marketing services to effectively navigate the complex regulatory environment. Additionally, the need for extensive field forces has driven the rise of contract sales organizations in the pharmaceutical sector. “By region, North America dominated the market in the healthcare BPO market in 2024” The healthcare BPO market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to maintain a significant market share during the forecast period. This growth is expected to be driven by factors such as increasing government support for improving healthcare infrastructure, the need to reduce healthcare costs, a rising volume of claims denials and billing errors, the high number of private healthcare payers and well-established government payers, and the presence of numerous healthcare IT companies. The break-down of primary participants is as mentioned below: • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%) • By Designation: C-level (30%), Director-level (20%), and Others (50%) • By Region: North America (42%), Europe (25%), Asia Pacific (21%), Latin America (7%), Middle East & Africa (5%) Key Players The major players operating in this market include Accenture plc. (Ireland), Cognizant Technology Solutions Corporation (US), Tata Consultancy Services Limited (India), Conduent Incorporated (US), WNS (Holdings) Limited (India), NTT Data Group Corporation (Japan), Iqvia Holdings Inc (US), Mphasis (India), Genpact Limited (US), Wipro Limited (India), Infosys BPM (India), Firstsource Solutions Limited (India), International Business Machines Corporation (US), GeBBS (US), Capgemini SE (France), Omega Healthcare Management Services (India), UnitedHealth Group (US), HCL Technologies Limited (India), Parexel International (MA) Corporation (US), Sutherland Global (US), 1840 & Company (US), Invensis Technologies (India), Access Healthcare (India), Vee Healthtek, Inc (US), and AGS Health (US). These companies adopted strategies such as expansions, partnerships, collaborations, and acquisitions to strengthen their market presence in the healthcare BPO market. Research Coverage This report examines the healthcare BPO market based on life science services, payer services, provider services, and region. It also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Additionally, it studies micro markets concerning their growth trends, prospects, and contributions to the overall healthcare BPO market. The report forecasts the revenue of the market segments in relation to five major regions. Reasons to Buy the Report This report will benefit established firms as well as new and smaller entrants in gauging the pulse of the market, which, in turn, will help them capture a larger share of the market. Firms purchasing the report could utilize one or a combination of the strategies mentioned below to strengthen their positions in the market. This report also includes. • Analysis of key drivers (shift to ICD-10 coding standards and upcoming ICD-11 standards, pressure to reduce the rising healthcare costs, loss of revenue due to billing errors, demand for niche services, need for structured processes and documentation, lack of in-house expertise in end-use industries, growing outsourcing in the pharma and biopharma industries), restraints (hidden outsourcing costs, concerns related to losing visibility and control over the business process), challenges (limitations in data capturing process in Medicaid services, data security concerns), opportunities (advanced data analytics, growing adoption of artificial intelligence-based tools for drug discovery) affecting the growth of the healthcare BPO market • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and service launches in the healthcare BPO market • Market Development: Comprehensive information on the lucrative emerging markets, life science services, payer services, provider services, and regions • Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the healthcare BPO market • Competitive Assessment: In-depth assessment of market share, growth strategies, service offerings, company evaluation quadrant, and capabilities of leading players in the global healthcare BPO market
目錄 Table of Contents
1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.2.1 LIFE SCIENCE SERVICE DEFINITION 30 1.2.2 PAYER SERVICE DEFINITION 30 1.2.3 PROVIDER SERVICE DEFINITION 32 1.2.4 INCLUSIONS & EXCLUSIONS 32 1.3 MARKET SCOPE 34 1.3.1 MARKETS COVERED 34 1.3.2 YEARS CONSIDERED 35 1.3.3 CURRENCY CONSIDERED 35 1.4 STAKEHOLDERS 36 2 RESEARCH METHODOLOGY 37 2.1 RESEARCH APPROACH 37 2.1.1 SECONDARY RESEARCH 38 2.1.1.1 Key data from secondary sources 39 2.1.2 PRIMARY DATA 39 2.1.2.1 Key data from primary sources 41 2.1.2.2 Key industry insights 41 2.2 MARKET SIZE ESTIMATION 42 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 47 2.4 STUDY ASSUMPTIONS 48 2.5 RESEARCH LIMITATIONS 48 2.5.1 METHODOLOGY-RELATED LIMITATIONS 48 2.5.2 SCOPE-RELATED LIMITATIONS 48 2.6 RISK ASSESSMENT 49 3 EXECUTIVE SUMMARY 50 4 PREMIUM INSIGHTS 54 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE BPO MARKET 54 4.2 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE AND COUNTRY 55 4.3 HEALTHCARE BPO MARKET: REGIONAL GROWTH OPPORTUNITIES 56 4.4 REGIONAL MIX: HEALTHCARE BPO MARKET 56 4.5 HEALTHCARE BPO NOTEBOOK MARKET: EMERGING VS. DEVELOPED ECONOMIES 57   5 MARKET OVERVIEW 58 5.1 INTRODUCTION 58 5.2 MARKET DYNAMICS 58 5.2.1 DRIVERS 59 5.2.1.1 Shift to ICD-10 coding standards and upcoming ICD-11 standard 59 5.2.1.2 Pressure to reduce rising healthcare costs 60 5.2.1.3 Loss of revenue due to billing errors 60 5.2.1.4 Demand for niche services 61 5.2.1.5 Need for structured processes and documentation 62 5.2.1.6 Lack of in-house expertise in end-use segments 62 5.2.1.7 Growing outsourcing in pharma and biopharma industries 62 5.2.2 RESTRAINTS 63 5.2.2.1 Hidden outsourcing costs 63 5.2.2.2 Concerns related to losing visibility and control over business process 64 5.2.3 OPPORTUNITIES 64 5.2.3.1 Advanced data analytics 64 5.2.3.2 Growing adoption of artificial intelligence-based tools for drug discovery 65 5.2.4 CHALLENGES 66 5.2.4.1 Limitations in data capturing process in Medicaid services 66 5.2.4.2 Data security concerns 66 5.3 OUTSOURCING APPROACHES 68 5.3.1 BUNDLED SERVICES 68 5.3.2 FEE FOR SERVICE 68 5.3.3 FLEXIBLE CONTRACTS 68 5.3.4 BEST-SHORE 68 5.4 OUTSOURCING MODELS 69 5.4.1 MULTI-SOURCING 69 5.4.2 CAPTIVE CENTER 69 5.4.3 HYBRID DELIVERY MODEL 70 5.4.4 PREFERRED PROVIDER 70 5.4.5 STRATEGIC PARTNERSHIP 71 5.4.6 GLOBAL DELIVERY MODEL 71 5.5 INDUSTRY TRENDS 72 5.5.1 DIGITAL TRANSFORMATION 72 5.5.2 RISE IN TELEHEALTH AND REMOTE SERVICES 72 5.5.3 FOCUS ON REVENUE CYCLE MANAGEMENT (RCM) 73 5.6 TECHNOLOGY ANALYSIS 73 5.6.1 KEY TECHNOLOGIES 73 5.6.1.1 Artificial intelligence and machine learning 73 5.6.1.2 Robotic process automation 74 5.6.1.3 Cloud computing 74 5.6.2 COMPLEMENTARY TECHNOLOGIES 74 5.6.2.1 Wearable devices and remote monitoring tools 74 5.6.2.2 Augmented reality and virtual reality 75 5.6.2.3 Data analytics and business intelligence 75 5.6.3 ADJACENT TECHNOLOGIES 75 5.6.3.1 Natural language processing (NLP) 75 5.6.3.2 Internet of medical things 76 5.6.3.3 Blockchain 76 5.7 SUPPLY CHAIN ANALYSIS 76 5.8 PORTER’S FIVE FORCE ANALYSIS 78 5.8.1 THREAT OF NEW ENTRANTS 79 5.8.2 THREAT OF SUBSTITUTES 79 5.8.3 BARGAINING POWER OF SUPPLIERS 79 5.8.4 BARGAINING POWER OF BUYERS 79 5.8.5 INTENSITY OF COMPETITIVE RIVALRY 80 5.9 REGULATORY LANDSCAPE 80 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 5.9.2 REGULATORY ANALYSIS 83 5.9.2.1 North America 83 5.9.2.2 Europe 84 5.9.2.3 Asia Pacific 85 5.9.2.4 Middle East & Africa 85 5.9.2.5 Latin America 86 5.10 PATENT ANALYSIS 86 5.10.1 PATENT PUBLICATION TRENDS 86 5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 87 5.11 PRICING ANALYSIS 89 5.11.1 INDICATIVE PRICE FOR HEALTHCARE BPO, BY SERVICE TYPE (2024) 90 5.11.2 INDICATIVE PRICE FOR HEALTHCARE BPO, BY REGION (QUALITATIVE) 90 5.12 KEY CONFERENCES AND EVENTS 91 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 92 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 92 5.13.2 BUYING CRITERIA 93 5.14 END-USER ANALYSIS 93 5.14.1 UNMET NEEDS 93 5.14.2 END-USER EXPECTATIONS 94 5.15 ECOSYSTEM ANALYSIS 96 5.16 CASE STUDY ANALYSIS 98 5.16.1 CASE STUDY 1 98 5.16.2 CASE STUDY 2 99 5.16.3 CASE STUDY 3 100 5.17 INVESTMENT & FUNDING SCENARIO 100 5.18 IMPACT OF 2025 US TARIFF – OVERVIEW 101 5.18.1 INTRODUCTION 101 5.18.2 KEY TARIFF RATES 101 5.18.3 PRICE IMPACT ANALYSIS 102 5.18.4 IMPACT ON COUNTRY/REGION 102 5.18.4.1 The US 102 5.18.4.2 Europe 103 5.18.4.3 Asia Pacific 103 5.18.5 IMPACT ON END-USE INDUSTRIES 104 6 HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE 105 6.1 INTRODUCTION 106 6.2 MANUFACTURING 106 6.2.1 INCREASING NEED TO REDUCE OVERALL OPERATIONAL COSTS TO DRIVE MARKET 106 6.3 RESEARCH & DEVELOPMENT 108 6.3.1 INCREASING DEMAND FOR SPECIALIZED R&D SERVICE PROVIDERS TO DRIVE MARKET GROWTH 108 6.4 NON-CLINICAL SERVICES 109 6.4.1 INCREASING NEED FOR ADMINISTRATIVE EFFICIENCY TO DRIVE MARKET 109 6.4.2 SALES & MARKETING SERVICES 111 6.4.2.1 Rising demand for strategic marketing and customer engagement to drive market 111 6.4.2.2 Analytics 112 6.4.2.2.1 Improved customer-facing functions and minimized risks to drive market 112 6.4.2.3 Marketing 113 6.4.2.3.1 Increasing focus on core functionalities to drive market 113 6.4.2.4 Research 114 6.4.2.4.1 Increasing focus on outsourcing research activities to drive market 114 6.4.2.5 Forecasting 115 6.4.2.5.1 Rapid technological advancements and shifts in consumer to drive market 115 6.4.2.6 Performance reporting 116 6.4.2.6.1 Availability of specialized vendors to drive market 116 6.4.3 SUPPLY CHAIN MANAGEMENT & LOGISTICS 117 6.4.3.1 COST-EFFECTIVE AND INNOVATIVE SUPPLY CHAIN SOLUTIONS TO DRIVE MARKET 117 6.4.4 OTHER NON-CLINICAL SERVICES 118   7 HEALTHCARE BPO MARKET, BY PAYER SERVICE 120 7.1 INTRODUCTION 121 7.2 CLAIMS MANAGEMENT SERVICES 122 7.2.1 INCREASING NEED FOR EFFICIENT, ACCURATE, AND COST-EFFECTIVE CLAIMS MANAGEMENT TO DRIVE MARKET 122 7.2.2 CLAIMS ADJUDICATION SERVICES 123 7.2.2.1 Scalability and flexibility to drive market 123 7.2.3 CLAIMS SETTLEMENT SERVICES 124 7.2.3.1 Streamlined settlement processes to drive market 124 7.2.4 INFORMATION MANAGEMENT SERVICES 125 7.2.4.1 Increasing need for specialized expertise to drive market 125 7.2.5 CLAIMS REPRICING 126 7.2.5.1 Reduced costs and enhanced service quality to drive market 126 7.2.6 CLAIMS INVESTIGATION SERVICES 127 7.2.6.1 Enhanced fraud detection and recovery to drive market 127 7.2.7 CLAIMS INDEXING SERVICES 128 7.2.7.1 Risk mitigation and compliance to drive market 128 7.2.8 FRAUD DETECTION & MANAGEMENT SERVICES 129 7.2.8.1 Increasing demand for social network analytics to drive market 129 7.3 INTEGRATED FRONT-END SERVICE & BACK-OFFICE OPERATIONS 130 7.3.1 REDUCTION IN OVERHEAD EXPENSES AND IMPROVED EFFICIENCY TO DRIVE MARKET 130 7.4 MEMBER MANAGEMENT 132 7.4.1 COST-EFFECTIVENESS AND OPERATIONAL EFFICIENCY TO DRIVE MARKET 132 7.5 PRODUCT DEVELOPMENT & BUSINESS ACQUISITION (PDBA) 133 7.5.1 INCREASING FOCUS ON CUSTOMER ENGAGEMENT AND RETENTION TO DRIVE MARKET 133 7.6 PROVIDER MANAGEMENT 134 7.6.1 IMPROVEMENT IN CLAIMS AUTO-ADJUDICATION RATES TO DRIVE MARKET 134 7.7 CARE MANAGEMENT 136 7.7.1 GROWING EMPHASIS ON PATIENT SATISFACTION AND OUTCOMES TO DRIVE MARKET 136 7.8 BILLING & ACCOUNTS MANAGEMENT SERVICES 137 7.8.1 ENHANCED BILLING ACCURACY AND EFFICIENCY TO DRIVE MARKET 137 7.9 HR SERVICES 138 7.9.1 INCREASING NEED FOR TALENT MANAGEMENT AND WORKFORCE ANALYTICS TO DRIVE MARKET 138   8 HEALTHCARE BPO MARKET, BY PROVIDER SERVICE 140 8.1 INTRODUCTION 141 8.2 REVENUE CYCLE MANAGEMENT 141 8.2.1 INCREASING OUTSOURCING OF MEDICAL BILLING AND MEDICAL CODING TO DRIVE MARKET 141 8.3 PATIENT ENROLMENT 143 8.3.1 INCREASED CLAIM DENIALS AND PAYMENT DELAYS TO DRIVE MARKET 143 8.4 PATIENT CARE 144 8.4.1 INCREASING NEED FOR EFFICIENT MANAGEMENT OF PATIENT INTERACTIONS AND CARE COORDINATION TO DRIVE MARKET 144 8.4.2 MEDICAL TRANSCRIPTION 146 8.4.2.1 Enhanced efficiency and productivity to drive market 146 8.4.3 DEVICE MONITORING 147 8.4.3.1 Increasing adoption of predictive analytics to drive market 147 8.4.4 MEDICAL IMAGING 147 8.4.4.1 Increasing need for advanced medical treatments to drive market 147 8.5 OTHER PROVIDER SERVICES 148 9 HEALTHCARE BPO MARKET, BY REGION 150 9.1 INTRODUCTION 151 9.2 NORTH AMERICA 151 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 153 9.2.2 US 157 9.2.2.1 Increasing healthcare expenditure support market growth in US 157 9.2.3 CANADA 160 9.2.3.1 Need for healthcare cost containment and financial management of healthcare organizations to support market growth 160 9.2.4 EUROPE 163 9.2.4.1 Need to reduce incidence of healthcare fraud to drive market growth 163 9.2.5 MACROECONOMIC OUTLOOK FOR EUROPE 164 9.2.6 GERMANY 168 9.2.6.1 Increasing patient volume to boost adoption of RCM services 168 9.2.7 FRANCE 171 9.2.7.1 Government investments to increase demand for effective healthcare BPO services 171 9.2.8 UK 174 9.2.8.1 Integration of advanced technology to boost demand for healthcare provider BPO services 174 9.2.9 ITALY 177 9.2.9.1 Government-supported digital transformation to drive market 177 9.2.10 SPAIN 180 9.2.10.1 IT infrastructural improvements to boost market 180 9.2.11 REST OF EUROPE 183 9.3 ASIA PACIFIC 187 9.3.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 188 9.3.2 JAPAN 192 9.3.2.1 Government mandates to boost adoption of RCM solutions 192 9.3.3 CHINA 195 9.3.3.1 Digitalization and improving infrastructure to support market growth 195 9.3.4 INDIA 199 9.3.4.1 Growing patient pool to support market growth 199 9.3.5 REST OF ASIA PACIFIC 202 9.4 LATIN AMERICA 205 9.4.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 206 9.4.2 BRAZIL 209 9.4.2.1 Brazil to dominate Latin American healthcare BPO market 209 9.4.3 MEXICO 213 9.4.3.1 Rising healthcare costs to boost market growth 213 9.4.4 REST OF LATIN AMERICA 216 9.5 MIDDLE EAST & AFRICA 219 9.5.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE SYSTEMS TO BOOST MARKET GROWTH 219 9.5.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 219 9.5.3 GCC COUNTRIES 223 9.5.3.1 Healthcare sector expansion and strategic investments to drive market 223 9.5.4 REST OF MIDDLE EAST & AFRICA 226 10 COMPETITIVE LANDSCAPE 230 10.1 OVERVIEW 230 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 230 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE BPO MARKET 231 10.3 REVENUE ANALYSIS, 2020-2024 233 10.4 MARKET SHARE ANALYSIS 234 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 236 10.5.1 STARS 237 10.5.2 EMERGING LEADERS 237 10.5.3 PERVASIVE PLAYERS 237 10.5.4 PARTICIPANTS 237 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 239 10.5.5.1 Region footprint 240 10.5.5.2 Provider service footprint 241 10.5.5.3 Payer service footprint 242 10.5.5.4 Life science service footprint 243   10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024 244 10.6.1 PROGRESSIVE COMPANIES 244 10.6.2 DYNAMIC COMPANIES 244 10.6.3 RESPONSIVE COMPANIES 244 10.6.4 STARTING BLOCKS 244 10.6.5 COMPETITIVE BENCHMARKING 246 10.6.5.1 Detailed list of key start-ups/SMEs 246 10.6.5.2 Competitive benchmarking of key start-ups/SMEs 246 10.7 COMPANY VALUATION & FINANCIAL METRICS 247 10.8 BRAND/PRODUCT COMPARISON ANALYSIS 248 10.9 COMPETITIVE SCENARIO 249 10.9.1 DEALS 249 10.9.2 EXPANSIONS 256 10.9.3 OTHER DEVELOPMENTS 257 11 COMPANY PROFILES 258 11.1 KEY PLAYERS 258 11.1.1 ACCENTURE PLC 258 11.1.1.1 Business overview 258 11.1.1.2 Services offered 259 11.1.1.3 Recent developments 260 11.1.1.3.1 Deals 260 11.1.1.4 MnM view 261 11.1.1.4.1 Right to win 261 11.1.1.4.2 Strategic choices 262 11.1.1.4.3 Weaknesses & competitive threats 262 11.1.2 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION 263 11.1.2.1 Business overview 263 11.1.2.2 Services offered 264 11.1.2.3 Recent developments 266 11.1.2.3.1 Deals 266 11.1.2.4 MnM view 267 11.1.2.4.1 Right to win 267 11.1.2.4.2 Strategic choices 267 11.1.2.4.3 Weaknesses & competitive threats 268 11.1.3 TATA CONSULTING SERVICES LIMITED 269 11.1.3.1 Business overview 269 11.1.3.2 Services offered 270 11.1.3.3 Recent developments 271 11.1.3.3.1 Deals 271 11.1.3.3.2 Other developments 272 11.1.3.4 MnM view 272 11.1.3.4.1 Right to win 272 11.1.3.4.2 Strategic choices 273 11.1.3.4.3 Weaknesses & competitive threats 273 11.1.4 WNS (HOLDINGS) LIMITED 274 11.1.4.1 Business overview 274 11.1.4.2 Services offered 275 11.1.4.3 Recent developments 276 11.1.4.3.1 Deals 276 11.1.4.3.2 Expansions 277 11.1.4.3.3 Other developments 277 11.1.4.4 MnM view 277 11.1.4.4.1 Right to win 277 11.1.4.4.2 Strategic choices 278 11.1.4.4.3 Weaknesses & competitive threats 278 11.1.5 NTT DATA 279 11.1.5.1 Business overview 279 11.1.5.2 Services offered 280 11.1.5.3 Recent developments 281 11.1.5.3.1 Deals 281 11.1.5.3.2 Expansions 281 11.1.5.4 MnM view 282 11.1.5.4.1 Right to win 282 11.1.5.4.2 Strategic choices 282 11.1.5.4.3 Weaknesses & competitive threats 282 11.1.6 CONDUENT INCORPORATED 283 11.1.6.1 Business overview 283 11.1.6.2 Services offered 284 11.1.6.3 Recent developments 285 11.1.6.3.1 Deals 285 11.1.7 IQVIA HOLDINGS INC. 286 11.1.7.1 Business overview 286 11.1.7.2 Services offered 287 11.1.7.3 Recent developments 288 11.1.7.3.1 Deals 288 11.1.7.3.2 Other developments 288 11.1.8 MPHASIS 289 11.1.8.1 Business overview 289 11.1.8.2 Services offered 290 11.1.8.3 Recent developments 291 11.1.8.3.1 Deals 291 11.1.8.3.2 Expansions 292 11.1.8.3.3 Other developments 292 11.1.9 GENPACT LIMITED 293 11.1.9.1 Business overview 293 11.1.9.2 Services offered 294 11.1.9.3 Recent developments 295 11.1.9.3.1 Deals 295 11.1.9.3.2 Expansions 296 11.1.10 WIPRO LIMITED 297 11.1.10.1 Business overview 297 11.1.10.2 Services offered 298 11.1.10.3 Recent developments 300 11.1.10.3.1 Deals 300 11.1.10.3.2 Other developments 300 11.1.11 INFOSYS BPM 301 11.1.11.1 Business overview 301 11.1.11.2 Services offered 303 11.1.12 FIRSTSOURCE SOLUTIONS LIMITED 304 11.1.12.1 Business overview 304 11.1.12.2 Services offered 306 11.1.12.3 Recent developments 306 11.1.12.3.1 Deals 306 11.1.12.3.2 Expansions 307 11.1.13 INTERNATIONAL BUSINESS MACHINES CORPORATION 308 11.1.13.1 Business overview 308 11.1.13.2 Services offered 309 11.1.13.3 Recent developments 310 11.1.13.3.1 Other developments 310 11.1.14 GEBBS 311 11.1.14.1 Business overview 311 11.1.14.2 Services offered 311 11.1.14.3 Recent developments 312 11.1.14.3.1 Deals 312 11.1.15 CAPGEMINI SE 313 11.1.15.1 Business overview 313 11.1.15.2 Services offered 314 11.1.16 UNITEDHEALTH GROUP INCORPORATED 315 11.1.16.1 Business overview 315 11.1.16.2 Services offered 316 11.1.17 HCL TECHNOLOGIES LIMITED 318 11.1.17.1 Business overview 318 11.1.17.2 Services offered 319 11.1.17.3 Recent developments 320 11.1.17.3.1 Deals 320 11.1.18 PAREXEL INTERNATIONAL (MA) CORPORATION 321 11.1.18.1 Business overview 321 11.1.18.2 Services offered 321 11.1.18.3 Recent developments 323 11.1.18.3.1 Deals 323 11.1.19 SUTHERLAND 324 11.1.19.1 Business overview 324 11.1.19.2 Services offered 325 11.1.20 OMEGA HEALTHCARE MANAGEMENT SERVICES 326 11.1.20.1 Business overview 326 11.1.20.2 Services offered 327 11.1.20.2.1 Other developments 328 11.2 OTHER PLAYERS 329 11.2.1 1840 & COMPANY 329 11.2.2 INVENSIS TECHNOLOGIES PVT LTD 330 11.2.3 ACCESS HEALTHCARE 331 11.2.4 VEE HEALTHTEK, INC. 332 11.2.5 AGS HEALTH 333 12 APPENDIX 334 12.1 DISCUSSION GUIDE 334 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 338 12.3 CUSTOMIZATION OPTIONS 340 12.4 RELATED REPORTS 340 12.5 AUTHOR DETAILS 341
圖表清單 List of Tables & Figures
TABLE 1 USD CONVERSION RATES 35 TABLE 2 RISK ASSESSMENT: HEALTHCARE BPO MARKET 49 TABLE 3 HEALTHCARE BPO MARKET: IMPACT ANALYSIS 59 TABLE 4 HEALTHCARE BPO MARKET: PORTER’S FIVE FORCES ANALYSIS 78 TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 10 LIST OF PATENTS IN HEALTHCARE BPO MARKET, 2014–2024 88 TABLE 11 INDICATIVE PRICE FOR HEALTHCARE BPO, BY SERVICE TYPE 90 TABLE 12 HEALTHCARE BPO MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 91 TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEALTHCARE BPO SERVICES 92 TABLE 14 KEY BUYING CRITERIA FOR HEALTHCARE BPO SERVICES 93 TABLE 15 HEALTHCARE BPO MARKET: UNMET NEEDS 94 TABLE 16 HEALTHCARE BPO MARKET: END USERS’ EXPECTATIONS 95 TABLE 17 HEALTHCARE BPO MARKET: ROLE IN ECOSYSTEM 97 TABLE 18 US ADJUSTED RECIPROCAL TARIFF RATES 101 TABLE 19 HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 106 TABLE 20 KEY PLAYERS PROVIDING MANUFACTURING SERVICES 107 TABLE 21 HEALTHCARE BPO MARKET FOR MANUFACTURING, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 22 KEY PLAYERS PROVIDING RESEARCH & DEVELOPMENT 108 TABLE 23 HEALTHCARE BPO MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 24 KEY PLAYERS PROVIDING NON-CLINICAL SERVICES 110 TABLE 25 HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 110 TABLE 26 HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 27 HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 112 TABLE 28 HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 29 HEALTHCARE BPO MARKET FOR ANALYTICS, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 30 HEALTHCARE BPO MARKET FOR MARKETING, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 31 HEALTHCARE BPO MARKET FOR RESEARCH, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 32 HEALTHCARE BPO MARKET FOR FORECASTING, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 33 HEALTHCARE BPO MARKET FOR PERFORMANCE REPORTING, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 34 HEALTHCARE BPO MARKET FOR SUPPLY CHAIN MANAGEMENT & LOGISTICS, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 35 HEALTHCARE BPO MARKET FOR OTHER NON-CLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 36 HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 121 TABLE 37 KEY PLAYERS PROVIDING CLAIM MANAGEMENT SERVICES 122 TABLE 38 HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 122 TABLE 39 HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 40 HEALTHCARE BPO MARKET FOR CLAIMS ADJUDICATION SERVICES, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 41 HEALTHCARE BPO MARKET FOR CLAIMS SETTLEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 42 HEALTHCARE BPO MARKET FOR INFORMATION MANAGEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 43 HEALTHCARE BPO MARKET FOR CLAIMS REPRICING SERVICES, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 44 HEALTHCARE BPO MARKET FOR CLAIMS INVESTIGATION SERVICES, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 45 HEALTHCARE BPO MARKET FOR CLAIMS INDEXING SERVICES, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 46 HEALTHCARE BPO MARKET FOR FRAUD DETECTION & MANAGEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 47 KEY PLAYERS PROVIDING INTEGRATED FRONT-END SERVICE & BACK-OFFICE OPERATIONS SERVICES 131 TABLE 48 HEALTHCARE BPO MARKET FOR INTEGRATED FRONT-END SERVICE & BACK-OFFICE OPERATIONS, BY REGION 2023–2030 (USD MILLION) 131 TABLE 49 KEY PLAYERS PROVIDING MEMBER MANAGEMENT SERVICES 132 TABLE 50 HEALTHCARE BPO MARKET FOR MEMBER MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 51 KEY PLAYERS PROVIDING PRODUCT DEVELOPMENT & BUSINESS ACQUISITION SERVICES 134 TABLE 52 HEALTHCARE BPO MARKET FOR PRODUCT DEVELOPMENT & BUSINESS ACQUISITION, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 53 KEY PLAYERS PROVIDING PROVIDER MANAGEMENT 135 TABLE 54 HEALTHCARE BPO MARKET FOR PROVIDER MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 55 KEY PLAYERS PROVIDING CARE MANAGEMENT SERVICES 136 TABLE 56 HEALTHCARE BPO MARKET FOR CARE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 57 KEY PLAYERS PROVIDING BILLING & ACCOUNTS MANAGEMENT SERVICES 138 TABLE 58 HEALTHCARE BPO MARKET FOR BILLING & ACCOUNTS MANAGEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 59 KEY PLAYERS PROVIDING HR SERVICES 139 TABLE 60 HEALTHCARE BPO MARKET FOR HR SERVICES, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 61 HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 141 TABLE 62 KEY PLAYERS PROVIDING REVENUE CYCLE MANAGEMENT SERVICES 142 TABLE 63 HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 64 KEY PLAYERS PROVIDING PATIENT ENROLMENT SERVICE 144 TABLE 65 HEALTHCARE BPO MARKET FOR PATIENT ENROLLMENT, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 66 KEY PLAYERS PROVIDING PATIENT CARE SERVICE 145 TABLE 67 HEALTHCARE BPO MARKET FOR PATIENT CARE, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 68 HEALTHCARE BPO MARKET FOR PATIENT CARE, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 69 HEALTHCARE BPO MARKET FOR MEDICAL TRANSCRIPTION, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 70 HEALTHCARE BPO MARKET FOR DEVICE MONITORING, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 71 HEALTHCARE BPO MARKET FOR MEDICAL IMAGING, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 72 KEY PLAYERS PROVIDING OTHER PROVIDER SERVICES 149 TABLE 73 HEALTHCARE BPO MARKET FOR OTHER PROVIDER SERVICES, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 74 HEALTHCARE BPO MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 75 NORTH AMERICA: HEALTHCARE BPO MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 76 NORTH AMERICA: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 154 TABLE 77 NORTH AMERICA: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 78 NORTH AMERICA: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICE, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 79 NORTH AMERICA: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 155 TABLE 80 NORTH AMERICA: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 81 NORTH AMERICA: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 156 TABLE 82 NORTH AMERICA: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 83 US: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 158 TABLE 84 US: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 85 US: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 86 US: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 159 TABLE 87 US: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 88 US: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 160 TABLE 89 US: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 90 CANADA: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 161 TABLE 91 CANADA: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 92 CANADA: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 93 CANADA: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 162 TABLE 94 CANADA: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 95 CANADA: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 163 TABLE 96 CANADA: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 97 EUROPE: HEALTHCARE BPO MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 98 EUROPE: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 165 TABLE 99 EUROPE: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 100 EUROPE: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 101 EUROPE: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 166 TABLE 102 EUROPE: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 103 EUROPE: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 167 TABLE 104 EUROPE: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 105 GERMANY: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 168 TABLE 106 GERMANY: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 107 GERMANY: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 108 GERMANY: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 169 TABLE 109 GERMANY: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 110 GERMANY: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 170 TABLE 111 GERMANY: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 112 FRANCE: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 172 TABLE 113 FRANCE: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 114 FRANCE: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 115 FRANCE: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 173 TABLE 116 FRANCE: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 117 FRANCE: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 174 TABLE 118 FRANCE: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 119 UK: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 175 TABLE 120 UK: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 121 UK: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 122 UK: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 176 TABLE 123 UK: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 124 UK: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 177 TABLE 125 UK: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 126 ITALY: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 178 TABLE 127 ITALY: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 128 ITALY: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 129 ITALY: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 179 TABLE 130 ITALY: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 131 ITALY: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 180 TABLE 132 ITALY: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 133 SPAIN: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 181 TABLE 134 SPAIN: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 135 SPAIN: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 136 SPAIN: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 182 TABLE 137 SPAIN: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 138 SPAIN: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 183 TABLE 139 SPAIN: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 140 REST OF EUROPE: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 184 TABLE 141 REST OF EUROPE: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 142 REST OF EUROPE: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 143 REST OF EUROPE: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 185 TABLE 144 REST OF EUROPE: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 145 REST OF EUROPE: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 186 TABLE 146 REST OF EUROPE: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 147 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 148 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 189 TABLE 149 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 150 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 151 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 190 TABLE 152 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 153 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 191 TABLE 154 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 155 JAPAN: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 192 TABLE 156 JAPAN: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 157 JAPAN: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 158 JAPAN: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 194 TABLE 159 JAPAN: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 160 JAPAN: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 195 TABLE 161 JAPAN: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 162 CHINA: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 196 TABLE 163 CHINA: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 164 CHINA: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 165 CHINA: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 197 TABLE 166 CHINA: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 167 CHINA: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 198 TABLE 168 CHINA: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 169 INDIA: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 199 TABLE 170 INDIA: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 171 INDIA: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 172 INDIA: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 201 TABLE 173 INDIA: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 174 INDIA: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 202 TABLE 175 INDIA: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 176 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 203 TABLE 177 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 178 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 179 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 204 TABLE 180 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 181 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 205 TABLE 182 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 183 LATIN AMERICA: HEALTHCARE BPO MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 184 LATIN AMERICA: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 206 TABLE 185 LATIN AMERICA: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 186 LATIN AMERICA: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 187 LATIN AMERICA: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 208 TABLE 188 LATIN AMERICA: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 189 LATIN AMERICA: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 209 TABLE 190 LATIN AMERICA: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 191 BRAZIL: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 210 TABLE 192 BRAZIL: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 193 BRAZIL: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 194 BRAZIL: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 211 TABLE 195 BRAZIL: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 196 BRAZIL: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 212 TABLE 197 BRAZIL: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 198 MEXICO: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 213 TABLE 199 MEXICO: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 200 MEXICO: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 201 MEXICO: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 214 TABLE 202 MEXICO: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 203 MEXICO: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 215 TABLE 204 MEXICO: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 205 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 216 TABLE 206 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 207 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 208 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 217 TABLE 209 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 210 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 218 TABLE 211 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 212 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 213 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 220 TABLE 214 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 215 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 216 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 221 TABLE 217 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 218 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 222 TABLE 219 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 220 GCC COUNTRIES: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 224 TABLE 221 GCC COUNTRIES: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 222 GCC COUNTRIES: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 223 GCC COUNTRIES: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 225 TABLE 224 GCC COUNTRIES: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 225 GCC COUNTRIES: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 226 TABLE 226 GCC COUNTRIES: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 227 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2023–2030 (USD MILLION) 227 TABLE 228 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR NON-CLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 229 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR SALES & MARKETING SERVICES, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 230 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2023–2030 (USD MILLION) 228 TABLE 231 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR CLAIMS MANAGEMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 232 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2023–2030 (USD MILLION) 229 TABLE 233 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR PATIENT CARE SERVICES, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 234 OVERVIEW OF STRATEGIES ADOPTED BY ADOPTED KEY PLAYERS IN HEALTHCARE BPO MARKET 231 TABLE 235 HEALTHCARE BPO MARKET: DEGREE OF COMPETITION 235 TABLE 236 HEALTHCARE BPO MARKET: REGION FOOTPRINT 240 TABLE 237 HEALTHCARE BPO MARKET: PROVIDER SERVICE FOOTPRINT 241 TABLE 238 HEALTHCARE BPO MARKET: PAYER SERVICE FOOTPRINT 242 TABLE 239 HEALTHCARE BPO MARKET: LIFE SCIENCE SERVICE FOOTPRINT 243 TABLE 240 HEALTHCARE BPO MARKET: KEY START-UPS/SMES 246 TABLE 241 HEALTHCARE BPO MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 246 TABLE 242 HEALTHCARE BPO MARKET: DEALS, JANUARY 2022–JUNE 2025 249 TABLE 243 HEALTHCARE BPO MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 256 TABLE 244 HEALTHCARE BPO MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 257 TABLE 245 ACCENTURE PLC: COMPANY OVERVIEW 258 TABLE 246 ACCENTURE PLC: SERVICES OFFERED 259 TABLE 247 ACCENTURE PLC: DEALS 260 TABLE 248 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY OVERVIEW 263 TABLE 249 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: SERVICES OFFERED 264 TABLE 250 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: DEALS 266 TABLE 251 TATA CONSULTING SERVICES LIMITED: COMPANY OVERVIEW 269 TABLE 252 TATA CONSULTING SERVICES LIMITED: SERVICES OFFERED 270 TABLE 253 TATA CONSULTING SERVICES LIMITED: DEALS 271 TABLE 254 TATA CONSULTING SERVICES LIMITED: OTHER DEVELOPMENTS 272 TABLE 255 WNS (HOLDINGS) LIMITED: COMPANY OVERVIEW 274 TABLE 256 WNS (HOLDINGS) LIMITED: SERVICES OFFERED 275 TABLE 257 WNS (HOLDINGS) LIMITED: DEALS 276 TABLE 258 WNS (HOLDINGS) LIMITED: EXPANSIONS 277 TABLE 259 WNS (HOLDINGS) LIMITED: OTHER DEVELOPMENTS 277 TABLE 260 NTT DATA: COMPANY OVERVIEW 279 TABLE 261 NTT DATA: SERVICES OFFERED 280 TABLE 262 NTT DATA: DEALS 281 TABLE 263 NTT DATA: EXPANSIONS 281 TABLE 264 NTT DATA: OTHER DEVELOPMENTS 281 TABLE 265 CONDUENT INCORPORATED: COMPANY OVERVIEW 283 TABLE 266 CONDUENT INCORPORATED: SERVICES OFFERED 284 TABLE 267 CONDUENT INCORPORATED: DEALS 285 TABLE 268 IQVIA HOLDINGS INC.: COMPANY OVERVIEW 286 TABLE 269 IQVIA HOLDINGS INC.: SERVICES OFFERED 287 TABLE 270 IQVIA HOLDINGS INC.: DEALS 288 TABLE 271 IQVIA HOLDINGS INC.: OTHER DEVELOPMENTS 288 TABLE 272 MPHASIS: COMPANY OVERVIEW 289 TABLE 273 MPHASIS: SERVICES OFFERED 290 TABLE 274 MPHASIS: DEALS 291 TABLE 275 MPHASIS: EXPANSIONS 292 TABLE 276 MPHASIS: OTHER DEVELOPMENTS 292 TABLE 277 GENPACT LIMITED: COMPANY OVERVIEW 293 TABLE 278 GENPACT LIMITED: SERVICES OFFERED 294 TABLE 279 GENPACT LIMITED: DEALS 295 TABLE 280 GENPACT LIMITED: EXPANSIONS 296 TABLE 281 WIPRO LIMITED.: COMPANY OVERVIEW 297 TABLE 282 WIPRO LIMITED: SERVICES OFFERED 298 TABLE 283 WIPRO LIMITED: DEALS 300 TABLE 284 WIPRO LIMITED: OTHER DEVELOPMENTS 300 TABLE 285 INFOSYS BPM: COMPANY OVERVIEW 301 TABLE 286 INFOSYS BPM: SERVICES OFFERED 303 TABLE 287 FIRSTSOURCE SOLUTIONS LIMITED: COMPANY OVERVIEW 304 TABLE 288 FIRSTSOURCE SOLUTIONS LIMITED: SERVICES OFFERED 306 TABLE 289 FIRSTSOURCE SOLUTIONS LIMITED: DEALS 306 TABLE 290 FIRSTSOURCE SOLUTIONS LIMITED: EXPANSIONS 307 TABLE 291 INTERNATIONAL BUSINESS MACHINES CORPORATION: COMPANY OVERVIEW 308 TABLE 292 INTERNATIONAL BUSINESS MACHINES CORPORATION: SERVICES OFFERED 309 TABLE 293 INTERNATIONAL BUSINESS MACHINES CORPORATION: OTHER DEVELOPMENTS 310 TABLE 294 GEBBS: COMPANY OVERVIEW 311 TABLE 295 GEBBS: SERVICES OFFERED 311 TABLE 296 GEBBS: DEALS 312 TABLE 297 CAPGEMINI SE: COMPANY OVERVIEW 313 TABLE 298 CAPGEMINI SE: SERVICES OFFERED 314 TABLE 299 UNITEDHEALTH GROUP INCORPORATED: COMPANY OVERVIEW 315 TABLE 300 UNITEDHEALTH GROUP INCORPORATED: SERVICES OFFERED 316 TABLE 301 HCL TECHNOLOGIES LIMITED: COMPANY OVERVIEW 318 TABLE 302 HCL TECHNOLOGIES LIMITED: SERVICES OFFERED 319 TABLE 303 HCL TECHNOLOGIES LIMITED: DEALS 320 TABLE 304 PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW 321 TABLE 305 PAREXEL INTERNATIONAL (MA) CORPORATION: SERVICES OFFERED 321 TABLE 306 PAREXEL INTERNATIONAL (MA) CORPORATION: DEALS 323 TABLE 307 SUTHERLAND: COMPANY OVERVIEW 324 TABLE 308 SUTHERLAND: SERVICES OFFERED 325 TABLE 309 OMEGA HEALTHCARE MANAGEMENT SERVICES: COMPANY OVERVIEW 326 TABLE 310 OMEGA HEALTHCARE MANAGEMENT SERVICES: SERVICES OFFERED 327 TABLE 311 OMEGA HEALTHCARE MANAGEMENT SERVICES: OTHER DEVELOPMENTS 328 FIGURE 1 HEALTHCARE BPO MARKET: RESEARCH DESIGN 37 FIGURE 2 SOURCES FOR PRIMARY INTERVIEWS 40 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 42 FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 43 FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 43 FIGURE 6 CAGR PROJECTIONS BY ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45 FIGURE 7 MARKET SIZE ESTIMATION: CAGR PROJECTIONS 46 FIGURE 8 HEALTHCARE BPO MARKET: DATA TRIANGULATION 47 FIGURE 9 HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE, 2025 VS. 2030 (USD MILLION) 50 FIGURE 10 HEALTHCARE BPO MARKET, BY PAYER SERVICE, 2025 VS. 2030 (USD MILLION) 51 FIGURE 11 CLAIMS MANAGEMENT SERVICE MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 52 FIGURE 12 HEALTHCARE BPO MARKET, BY PROVIDER SERVICE, 2025 VS. 2030 (USD MILLION) 52 FIGURE 13 HEALTHCARE BPO MARKET: REGIONAL SNAPSHOT 53 FIGURE 14 GROWING NEED TO REDUCE HEALTHCARE COSTS TO DRIVE MARKET GROWTH 54 FIGURE 15 MANUFACTURING SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET 55 FIGURE 16 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 56 FIGURE 17 NORTH AMERICA TO LEAD HEALTHCARE BPO MARKET DURING FORECAST PERIOD 56 FIGURE 18 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 57 FIGURE 19 HEALTHCARE BPO MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58 FIGURE 20 US: MEDIAN HEALTHCARE DATA BREACHES, 2009–2024 67 FIGURE 21 HEALTHCARE BPO MARKET: SUPPLY CHAIN ANALYSIS 77 FIGURE 22 HEALTHCARE BPO MARKET: PORTER’S FIVE FORCES ANALYSIS 78 FIGURE 23 GLOBAL PATENT PUBLICATION TRENDS IN HEALTHCARE BPO MARKET, 2014–2024 86 FIGURE 24 TOP PATENT APPLICANTS IN HEALTHCARE BPO MARKET (2014−2024) 87 FIGURE 25 TOP JURISDICTION: HEALTHCARE BPO MARKET (2014−2024) 88 FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEALTHCARE BPO SERVICES 92 FIGURE 27 KEY BUYING CRITERIA FOR HEALTHCARE BPO SERVICES 93 FIGURE 28 HEALTHCARE BPO MARKET: ECOSYSTEM ANALYSIS 96 FIGURE 29 HEALTHCARE BPO MARKET: INVESTMENT & FUNDING SCENARIO 100 FIGURE 30 NORTH AMERICA: HEALTHCARE BPO MARKET SNAPSHOT 153 FIGURE 31 ASIA PACIFIC: HEALTHCARE BPO MARKET SNAPSHOT 188 FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS FOR HEALTHCARE BPO MARKET (2020–2024) 233 FIGURE 33 HEALTHCARE BPO MARKET: MARKET SHARE ANALYSIS (2024) 234 FIGURE 34 HEALTHCARE BPO MARKET: COMPANY EVALUATION MATRIX, 2024 238 FIGURE 35 COMPANY FOOTPRINT 239 FIGURE 36 HEALTHCARE BPO MARKET: START-UPS/SMES EVALUATION MATRIX (2024) 245 FIGURE 37 EV/EBITDA OF KEY VENDORS 247 FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 248 FIGURE 39 HEALTHCARE BPO MARKET: BRAND/PRODUCT COMPARISON ANALYSIS 248 FIGURE 40 ACCENTURE PLC: COMPANY SNAPSHOT (2024) 259 FIGURE 41 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY SNAPSHOT (2024) 264 FIGURE 42 TATA CONSULTING SERVICES LIMITED: COMPANY SNAPSHOT (2024) 270 FIGURE 43 WNS (HOLDINGS) LIMITED: COMPANY SNAPSHOT (2024) 275 FIGURE 44 NTT DATA: COMPANY SNAPSHOT (2024) 280 FIGURE 45 CONDUENT INCORPORATED: COMPANY SNAPSHOT (2024) 284 FIGURE 46 IQVIA HOLDINGS INC.: COMPANY SNAPSHOT (2024) 287 FIGURE 47 MPHASIS: COMPANY SNAPSHOT (2024) 290 FIGURE 48 GENPACT LIMITED: COMPANY SNAPSHOT (2024) 294 FIGURE 49 WIPRO LIMITED: COMPANY SNAPSHOT (2024) 298 FIGURE 50 INFOSYS BPM: COMPANY SNAPSHOT (2024) 302 FIGURE 51 FIRSTSOURCE SOLUTIONS LIMITED: COMPANY SNAPSHOT (2024) 305 FIGURE 52 INTERNATIONAL BUSINESS MACHINES CORPORATION: COMPANY SNAPSHOT (2024) 309 FIGURE 53 CAPGEMINI SE: COMPANY SNAPSHOT (2024) 314 FIGURE 54 UNITEDHEALTH GROUP INCORPORATED: COMPANY SNAPSHOT (2024) 316 FIGURE 55 HCL TECHNOLOGIES LIMITED: COMPANY SNAPSHOT (2024) 319

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們